Compare · 2 funds side by side · dividends reinvested

PSCH and IDNA

PSCHInvesco×IDNAiShares×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$9,191PSCH · best of the two

02 / 04

PSCH and IDNA, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.66%+62.2%+71.4%+33.7%−2.2%−10.6%30.6%$346M1.4

Invesco S&P SmallCap Health Care ETFSectors · Health care0.29%0.00%+26.5%+30.5%+16.2%−1.7%−15.4%20.4%$181M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 6, 2026 · returns include dividends · since: PSCH 2010 · IDNA 2019

Head to Head

Swap sides Versus in desk

Head to Head

Invesco S&P SmallCap Health Care ETF · $181M$9,191

PSCH

IDNA

iShares Genomics Immunology and Healthcare ETF · $346M$8,930

$10,000 five years ago, dividends reinvested · they hold 2.4% in common

PSCHMeasureIDNA

+26.5%Year to dateJan 1 → Nov 6+62.2%

+30.5%1 yearTotal return+71.4%

+16.2%3 years · per year$10,000 became $15,673 · $23,890+33.7%

−1.7%5 years · per year$10,000 became $9,191 · $8,930−2.2%

0.29%Expense ratio$29 · $47 a year on $10k · lower is better0.47%

0.00%Trailing 12-mo yield$0 · $66 a year on $10k0.66%

−15.4%Worst dropSmaller is better−10.6%

20.4%VolatilityLower is calmer30.6%

PSCHIDNA Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5IDNA wins

End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PSCH vs IDNA: Top 5 Holdings

Today

PSCH

20.1%in top 5

IDNA

in top 533.8%

PSCHStockIDNA

not top 5MRNA14.4%

not top 5GMAB.CO6.3%

not top 5TWST4.9%

4.8%PTGXnot top 5

4.5%TGTXnot top 5

not top 5BAYN.DE4.3%

4.1%ALKSnot top 5

not top 5REGN4.0%

3.5%TFXnot top 5

3.2%LGNDnot top 5

Held in common2.4%

End-of-day Nov 6, 2026 · share of each fund

PSCH vs IDNA Returns, Every Period

InvescoPSCH

−1.7%

5 years, per year

IDNAiShares

−2.2%

5 years, per year

PSCHIDNAFaded: behind in that period

1–3IDNA wins

End-of-day Nov 6, 2026 · dividends in · faded = behind in that period

PSCH vs IDNA

YTD

InvescoPSCH

+26.5%

IDNAiShares

+62.2%

+26.5%Year to date+62.2%

−15.4%Worst drop · 1Y−10.6%

20.4%Volatility · 1Y30.6%

0.0%Yield0.7%

$181MAssets$346M

3–1IDNA wins

End-of-day Nov 6, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PSCH, IDNA

Today

0.29%lowest, PSCH

FundExpense ratioFee$10k

PSCH0.29%$29

IDNA0.47%$47

End-of-day Nov 6, 2026 · fee on $10,000 a year

Yields: PSCH, IDNA

0.66%highest, IDNA

FundTrailing yieldYield$10k

IDNA0.66%$66

PSCH0.00%$0

End-of-day Nov 6, 2026 · trailing 12-month yield

Income After Fees on $10,000

$19most kept, IDNA

IDNA$66 − $47 = $19

PSCH$0 − $29 = −$29

KeptFee

End-of-day Nov 6, 2026 · yield in dollars minus the fee

Overlap: PSCH, IDNA

Today

2.4%most shared, PSCH and IDNA

PSCHIDNA

PSCH—2.4%

IDNA2.4%—

End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+71.4%IDNA, at 30.6% volatility

PSCHWorst drop−15.4%20.4% vol

IDNAWorst drop−10.6%30.6% vol

End-of-day Nov 6, 2026 · up and left is better

Paid More vs Made More

YTD

IDNAPSCH

+62.2%Year to date+26.5%

0.7%Yield0.0%

+71.4%Past year+30.5%

0.47%Fee0.29%

3–1IDNA wins

End-of-day Nov 6, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+31.4%

VIGVanguard

+12.1%

+31.4%Year to date+12.1%

3.0%Yield1.5%

$120BAssets$109B

2–0SCHD wins

End-of-day Nov 6, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+3.2%

JEPIJ.P. Morgan

+5.3%

+3.2%Year to date+5.3%

12.8%Yield8.1%

$40.7BAssets$45.2B

1–1level

End-of-day Nov 6, 2026

SPYM vs SPY

YTD

SPDRSPYM

+8.8%

SPYSPDR

+8.7%

+8.8%Year to date+8.7%

1.1%Yield1.0%

$178BAssets$778B

2–0SPYM wins

End-of-day Nov 6, 2026